𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcome of ten years’ echocardiographic follow-up in children with Gaucher disease

✍ Scribed by Dror Rosengarten; Aya Abrahamov; Amiram Nir; Benjamin Farber; Joram Glaser; Ari Zimran; Deborah Elstein

Publisher
Springer
Year
2006
Tongue
English
Weight
72 KB
Volume
166
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mental outcome following encephaloduroar
Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age
✍ Yoshiharu Matsushima; Masaru Aoyagi; Hiroyuki Masaoka; Ryuta Suzuki; Kikuo Ohno 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 349 KB

The mental prognosis of children with moyamoya disease, in whom the onset was when they were younger than 5 years of age, has been reported to be very poor. We studied the mental outcome of these patients after encephaloduroarteriosynangiosis (EDAS) in relation to the age at the onset of the disease

Rhabdomyosarcoma of the soft palate in t
Rhabdomyosarcoma of the soft palate in three patients with follow-up of longer than ten years
✍ Maso, Maurizio Dal ;Kushner, Joseph H. ;Dedo, Herbert H. 📂 Article 📅 1986 🏛 Wiley (John Wiley & Sons) ⚖ 423 KB

Rhabdomyosarcoma of the head and neck is a rare childhood neoplasm. Most occur in the orbit, which accounts for the scarcity of papers on modem techniques of treatment of soft palate rhabdomyosarcomas. Only 30 cases of soft palate rhabdomyosarcoma have been reported in recent years and none had long

Ten-year follow-up of Parkinson's diseas
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
✍ Robert A. Hauser; Olivier Rascol; Amos D. Korczyn; A. Jon Stoessl; Ray L. Watts; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract In a 5‐year, double‐blind study, subjects with Parkinson's disease (PD) who were randomized to initial treatment with ropinirole had a significantly lower incidence of dyskinesia compared with subjects randomized to levodopa, although Unified Parkinson's Disease Rating Scale (UPDRS) mot